Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2026-03-09 @ 7:26 AM
Study NCT ID:
NCT05876312
Status:
RECRUITING
Last Update Posted:
2024-11-15
First Post:
2023-05-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Sponsor:
ADARx Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-17
First Submit QC Date:
None
Study First Post Date:
2023-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-12
Last Update Post Date:
2024-11-15
Last Update Post Date Type:
ACTUAL